123 related articles for article (PubMed ID: 8713695)
1. Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis.
Charalambous D; O'Brien PE
J Gastroenterol Hepatol; 1996 Apr; 11(4):307-10. PubMed ID: 8713695
[TBL] [Abstract][Full Text] [Related]
2. Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats.
Charalambous D; Farmer C; O'Brien PE
J Gastroenterol Hepatol; 1996 Jan; 11(1):88-92. PubMed ID: 8672749
[TBL] [Abstract][Full Text] [Related]
3. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
Martin JE; Young GP; LE Leu RK; Hu Y
Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
[TBL] [Abstract][Full Text] [Related]
7. Sulindac inhibits colorectal tumour growth, but not prostaglandin synthesis in the rat.
Charalambous D; Skinner SA; O'Brien PE
J Gastroenterol Hepatol; 1998 Dec; 13(12):1195-200. PubMed ID: 9918425
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
Wargovich MJ; Chen CD; Harris C; Yang E; Velasco M
Int J Cancer; 1995 Feb; 60(4):515-9. PubMed ID: 7829266
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
[TBL] [Abstract][Full Text] [Related]
11. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
Schnitzler M; Dwight T; Robinson BG
Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effect of sulindac in combination with epigallocatechin gallate or kaempferol against 1,2-dimethyl hydrazine-induced preneoplastic lesions in rats: A Comparative Study.
Hassanein NMA; Hassan ESG; Hegab AM; Elahl HMS
J Biochem Mol Toxicol; 2018 Oct; 32(10):e22198. PubMed ID: 29999212
[TBL] [Abstract][Full Text] [Related]
13. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods.
Tudek B; Bird RP; Bruce WR
Cancer Res; 1989 Mar; 49(5):1236-40. PubMed ID: 2917353
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis.
Barnes CJ; Cameron IL; Hardman WE; Lee M
Br J Cancer; 1998 Feb; 77(4):573-80. PubMed ID: 9484814
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acid does not inhibit development of aberrant crypt foci in colons of male Sprague-Dawley rats.
Ealey KN; el-Sohemy A; Archer MC
Nutr Cancer; 2001; 41(1-2):104-6. PubMed ID: 12094611
[TBL] [Abstract][Full Text] [Related]
17. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
18. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
Magnuson BA; Bird RP
Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
[TBL] [Abstract][Full Text] [Related]
19. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions.
Pretlow TP; O'Riordan MA; Pretlow TG; Stellato TA
J Cell Biochem Suppl; 1992; 16G():55-62. PubMed ID: 1361589
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effect of squalene on colon cancer.
Rao CV; Newmark HL; Reddy BS
Carcinogenesis; 1998 Feb; 19(2):287-90. PubMed ID: 9498278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
